IL13 and Alzheimer disease: Immunologically, AD is mainly characterized as a type‐2 inflammation with high levels of Th2 and ILC2‐driven IL‐4/IL‐13, IL‐5, and IL‐9, IgE‐producing B cells, and high levels of serum IgE [6].